Accueil/Actions/CINGW

CINGW

USD

Cingulate Inc. Warrants

$0.031-0.007 (-18.750%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$0.038

Haut

$0.031

Bas

$0.031

Volume

0.01M

Fondamentaux de l'Entreprise

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.0311Actuel $0.031Haut $0.0312

Actualités Connexes

28 oct. 2025 · 12:00

GlobeNewswire

Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Efficacy and Entire Active-Day Symptom Control

KANSAS CITY, Kan., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing its proprietary

Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Efficacy and Entire Active-Day Symptom Control

23 oct. 2025 · 20:45

GlobeNewswire

Cingulate's Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting

KANSAS CITY, Kan., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing its proprietary